SARASOTA, Fla.–(BUSINESS WIRE)–As summer winds down and kids head back to school, a top concern for parents is how to prevent communicable diseases like pink eye from penetrating their households. Unknown to most parents, many doctors often have difficulty differentiating between viral and bacterial cases of pink eye. That is why Robert Sambursky, MD, CEO and President of RPS Diagnostics (RPS®) developed AdenoPlus®, a rapid, in-office test that detects all known serotypes of adenoviral conjun
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2016. “The second half of 2016 will be a busy time for Ocular Therapeutix as we prepare to initiate the first of two planned Phase 3 clinical trials with OTX-TP for the treatment of glaucoma and ocular hypertensio
At Kiawah Eye, Savak “Sev” Teymoorian, MD, MBA, gives pearls on challenging cases of minimally invasive glaucoma surgery.
In a study published online by JAMA Ophthalmology, Paul D. Loprinzi, Ph.D., of the University of Mississippi, University, Miss.
Valeant Pharmaceuticals International has announced leadership and organizational changes.Christina Ackermann has been named executive vice president and general counsel, according to a press release. She succeeds Robert Chai-Onn, who will leave Valean…
HEIDELBERG, Germany–(BUSINESS WIRE)–#3D–Live 3D imaging is one of the hottest topics in optics today, transforming medical imaging capabilities and delivering the immersive experience behind augmented and virtual reality.